Literature DB >> 16166103

Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome.

M Pertovaara1, J Antonen, M Hurme.   

Abstract

BACKGROUND: Immunohistological studies on salivary and lacrimal glands have yielded conflicting results on the Th1/Th2 balance in primary Sjögren's syndrome (pSS).
OBJECTIVE: To establish whether pSS is a Th1 or Th2 directed autoimmune disease by analysing the polymorphism of the genes encoding for cytokines involved in the regulation of Th1/Th2 differentiation.
METHODS: The polymorphisms of the genes encoding for interleukin 4 (IL4) -590 C/T, interleukin 13 (IL13) +2044 G/A, and interferon gamma (IFNG) +874 T/A were analysed in 63 white Finnish patients with pSS (61 female, two male) and in 63 healthy controls. The clinical and immunological data on the pSS patients were analysed in relation to these cytokine gene polymorphisms.
RESULTS: There were no significant differences in the genotype or allele frequencies of IL4 -590, IL13 +2044, or IFNG +874 between pSS patients and controls. The erythrocyte sedimentation rate and concentrations of serum IgA and serum beta2 microglobulin were lower in pSS patients carrying the IL4 -590 T allele or the IL13 +2044 A allele than in those not carrying the respective alleles. The IL4 -509 T allele and IL13 +2044 A allele carriers less often had purpura than the corresponding non-carriers.
CONCLUSIONS: The frequencies of the cytokine genotypes regulating Th1/Th2 differentiation did not differ between pSS patients and controls. However, the presence of cytokine genotypes with increased susceptibility to atopic and other Th2 diseases was associated with signs of a milder form of pSS. This finding would favour a hypothesis envisaging pSS as primarily a Th1 mediated autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166103      PMCID: PMC1798135          DOI: 10.1136/ard.2005.040956

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.

Authors:  E C Kolkowski; P Reth; F Pelusa; J Bosch; R Pujol-Borrell; J Coll; D Jaraquemada
Journal:  J Autoimmun       Date:  1999-08       Impact factor: 7.094

2.  T(H)1 cytokines are produced in labial salivary glands in Sjögren's syndrome, but also in healthy individuals.

Authors:  Y T Konttinen; P Kemppinen; H Koski; T F Li; M Jumppanen; J Hietanen; S Santavirta; T Salo; A Larsson; M Hakala; T Sorsa
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

3.  Association between IL-4 genotype and IL-4 production in the Japanese population.

Authors:  H Nakashima; K Miyake; Y Inoue; S Shimizu; M Akahoshi; Y Tanaka; T Otsuka; M Harada
Journal:  Genes Immun       Date:  2002-04       Impact factor: 2.676

4.  Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome.

Authors:  R A Ajjan; R S McIntosh; E A Waterman; P F Watson; C D Franklin; C M Yeoman; A P Weetman
Journal:  Br J Rheumatol       Date:  1998-02

5.  Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.

Authors:  G M Villarreal; J Alcocer-Varela; L Llorente
Journal:  Immunol Lett       Date:  1996-01       Impact factor: 3.685

6.  The occurrence of renal involvement in primary Sjögren's syndrome: a study of 78 patients.

Authors:  M Pertovaara; M Korpela; T Kouri; A Pasternack
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

7.  Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.

Authors:  D A Jabs; B Lee; J A Whittum-Hudson; R A Prendergast
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

8.  Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.

Authors:  M Garcíc-Carrasco; J Font; X Filella; R Cervera; M Ramos-Casals; A Sisó; A Aymamí; A M Ballesta; M Ingelmo
Journal:  Clin Exp Rheumatol       Date:  2001 Jul-Aug       Impact factor: 4.473

9.  Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome.

Authors:  E Hagiwara; J Pando; Y Ishigatsubo; D M Klinman
Journal:  J Rheumatol       Date:  1998-01       Impact factor: 4.666

10.  Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma.

Authors:  E Noguchi; Y Nukaga-Nishio; Z Jian; Y Yokouchi; M Kamioka; K Yamakawa-Kobayashi; H Hamaguchi; A Matsui; M Shibasaki; T Arinami
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

View more
  12 in total

Review 1.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

Review 2.  T helper cytokines in dry eye disease.

Authors:  Stephen C Pflugfelder; Rosa M Corrales; Cintia S de Paiva
Journal:  Exp Eye Res       Date:  2013-09-04       Impact factor: 3.467

3.  The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers.

Authors:  M Pertovaara; M Heliövaara; A Raitala; S S Oja; P Knekt; M Hurme
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

4.  [Sjögren's syndrome. Current aspects from a rheumatological point of view].

Authors:  C Tomiak; T Dörner
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

5.  Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Authors:  Qing Lan; Tongzhang Zheng; Nathaniel Rothman; Yawei Zhang; Sophia S Wang; Min Shen; Sonja I Berndt; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Meredith Yeager; Robert Welch; Peter Boyle; Bing Zhang; Kaiyong Zou; Yong Zhu; Stephen Chanock
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

6.  Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates crescentic glomerulonephritis.

Authors:  Weiping Hou; Suzhi Li; Yinping Wu; Xiang Du; Fahuan Yuan
Journal:  Clin Exp Immunol       Date:  2009-03-11       Impact factor: 4.330

Review 7.  Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Authors:  Terry G Coursey; Cintia S de Paiva
Journal:  Clin Ophthalmol       Date:  2014-08-04

8.  Correlation of interleukin-33 with Th cytokines and clinical severity of dry eye disease.

Authors:  Guoping Luo; Yan Xin; Dajun Qin; Aihua Yan; Zhiyan Zhou; Zhaoxia Liu
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

Review 9.  T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome.

Authors:  William de Jesús Ríos-Ríos; Sorely Adelina Sosa-Luis; Honorio Torres-Aguilar
Journal:  Biomolecules       Date:  2020-11-11

10.  Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility.

Authors:  Maha Ali M Al-Mohaya; Lubna Al-Otaibi; Fahad Al-Harthi; Ebtissam Al Bakr; Misbahul Arfin; Abdulrahman Al-Asmari
Journal:  BMC Oral Health       Date:  2016-08-20       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.